Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.1.2 - 1.1.2
Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.1.2 - 1.1.2
Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: Composition
ResourceComposition "8a07e353-9cf6-4f27-8a30-2c2d4f439847"
Profile: eCTD Product Characterisation of Impurities Composition
status: final
type: Product Characterisation of Impurities (Code System PQCMC Comp Section Types#32P55)
date: 2024-04-24 01:12:07+0000
author: urn:uuid:98effc99-db2b-428d-89aa-0ce426e02788
title: eCTD Product Characterisation of Impurities Composition for TabletCoatedBeadsCoatedAll
IG © 2021+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.us.pq-cmc-fda#1.1.2 based on FHIR 5.0.0. Generated 2024-06-24
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change